Allergan Faces NJ Patent Suit Over Generic ADHD Medication
Rhodes Pharmaceuticals LP on Friday challenged Allergan PLC's request for approval of a generic version of attention deficit hyperactivity disorder medication Aptensio XR, contending in a New Jersey federal court suit...To view the full article, register now.
Already a subscriber? Click here to view full article